how do glp-1 cause weight loss GLP-1R Agonists for What Are GLP-1 Agonists For

You are still on the starting dose, but with two to four injections behind you, cumulative drug exposure is increasing

No membership required

Clinical Implications Beyond Diabetes and Obesity While retatrutide is being tested primarily for obesity and type 2 diabetes , its impact on LDL suggests future use in: Cardiovascular disease prevention (alongside statins or in statin-intolerant patients) Metabolic syndrome management Nonalcoholic fatty liver disease (NAFLD/NASH) , since LDL and triglyceride metabolism are central to liver health Complementary to Statins Unlike statins, which only reduce LDL synthesis, retatrutide may work through multiple lipid pathways , making it synergistic rather than redundant

Therefore, it is hypothesized that ghrelin synthesized within the hypothalamus, as opposed to gut-derived ghrelin, is the mediator of central orexigenic effects of ghrelin, although further research is needed 224

Two main limitations include the use of 2021 as the most recent data and coding errors

The American Journal of Clinical Nutrition